Drug
Aflibercept Ave0005
Aflibercept Ave0005: highest development phase Phase 3, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| AFLIBERCEPT AVE0005 NCT01571284 | Phase 3 | Colorectal Cancer Metastatic |
Latest
No recent events.
Follow Aflibercept Ave0005 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.